Vanda Pharmaceuticals reported $60.19M in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acadia Pharmaceuticals ACAD:US $ 115.47M 15.29M
Acorda Therapeutics ACOR:US $ 22.53M 14.43M
Akebia Therapeutics AKBA:US $ 61.7M 2.09M
Alnylam Pharmaceuticals ALNY:US $ 213.26M 45.28M
Anika Therapeutics ANIK:US $ 36.69M 0.87M
Arrowhead Research ARWR:US $ 151.8M 124.37M
AstraZeneca AZN:LN 11390M 621M
Bluebird Bio BLUE:US $ 1.94M 0.34M
Bristol Myers Squibb BMY:US $ 11648M 337M
Clovis Oncology CLVS:US $ 34.25M 1.72M
Eli Lilly And LLY:US $ 7810M 189.9M
Enanta Pharmaceuticals ENTA:US $ 18.72M 8.93M
Esperion Therapeutics ESPR:US $ 18.84M 3.44M
Halozyme Therapeutics HALO:US $ 117.28M 15.28M
Heron Therapeutics HRTX:US $ 23.46M 2.8M
Insmed INSM:US $ 53.11M 3.02M
Intercept Pharmaceuticals ICPT:US $ 88.58M 3.82M
Johnson & Johnson JNJ:US $ 23426M 1378M
Lexicon Pharmaceuticals LXRX:US $ 0.04M 0.02M
Ligand Pharmaceuticals LGND:US $ 45.69M 26.78M
Merk MRK:US $ 15901M 2380M
Moderna Inc MRNA:US 6.07B 1.14B
Novartis NVS:US $ 12814M 708M
Ptc Therapeutics PTCT:US $ 148.74M 16.49M
Puma Biotechnology PBYI:US $ 45.74M 9.62M
Sangamo Biosciences SGMO:US $ 28.23M 0.24M
Takeda 4502:JP Y 873289M 28005M
Teva Pharmaceutical TEVA:IT 3.66B 439M
Ultragenyx Pharmaceutical RARE:US $ 79.94M 3.45M
Vanda Pharmaceuticals VNDA:US $ 60.19M 7.83M
Veracyte VCYT:US $ 67.78M 0.45M